SEC Form 4 filed by Natural Alternatives International Inc.
$NAII
Medicinal Chemicals and Botanical Products
Health Care
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)
8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)
10-Q - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)
SCHEDULE 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)
New proprietary formulation delivers more than four times the bioavailability of standard beta-alanine without paresthesia. Natural Alternatives International, Inc. (NAI) is launching CarnoSyn® 4X, the most advanced CarnoSyn® beta-alanine formulation to date. The ingredient delivers more than four times the bioavailability of standard beta-alanine without paresthesia, the tingling sensation often associated with beta-alanine usage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420814198/en/For decades, CarnoSyn® has helped everyday and elite athletes train harder and recover faster. CarnoSyn® 4X quadruples bioavailability
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2025, increased $0.7 million, or 2%, to $34.8 million as compared to $34.1 million recorded in the comparable prior year period. During the same period, private-label contract m
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2025, increased $4.6 million, or 13.8%, to $37.7 million as compared to $33.2 million recorded in the comparable prior year period. During the same period, private-label contract m
CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ -- -Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2021 decreased $1.4 million, or 3.5%, to $38.3 million as compared to $39.7 million recorded in the comparable prior year period. During the same period, private-label contract man
CARLSBAD, Calif., May 13, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.9 million, or $0.30 per diluted share, on net sales of $46.3 million for the third quarter of fiscal year 2021 compared to a net loss of $4.0 million, or $0.61 per diluted share, in the third quarter of the prior fiscal year. Our results for the third quarter of fiscal 2020 included the negative impact of a $4.3 million accounts receivable and inventory reserve related to a former customer, which was not repeated in the third quarter of fiscal 2021. Net s
SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)
SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)
SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)
CARLSBAD, Calif., July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. Over the course of his 25 plus year career in the domestic and international nutritional supplement industry, Conti has established a proven track record of success in building new business within multiple markets. "Shan
CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands. In his new role, Starr will be responsible for the leadership of business teams and for overseeing operational performance and the advancement of CarnoSyn® Brands. "I am pleased to announce Aaron Starr has been named Vice President of CarnoSyn® Brands," said Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International. "Aaron has been a valued member of our team for many year
LAVAL, QC, Sept. 27, 2021 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced the appointment of Randy Weaver as Interim Chief Financial Officer while retaining Dr. Toni Rinow as Chief Operating Officer. Mr. Weaver joins Neptune as Interim Chief Financial Officer with a successful track record of leading numerous CPG companies as a senior executive, bringing the knowledge and e